Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Jul 18;11(7):e0159347.
doi: 10.1371/journal.pone.0159347. eCollection 2016.

Neutralizing Antibodies against Plasmodium falciparum Associated with Successful Cure after Drug Therapy

Affiliations

Neutralizing Antibodies against Plasmodium falciparum Associated with Successful Cure after Drug Therapy

Yun Shan Goh et al. PLoS One. .

Abstract

An effective antibody response can assist drug treatment to contribute to better parasite clearance in malaria patients. To examine this, sera were obtained from two groups of adult patients with acute falciparum malaria, prior to drug treatment: patients who (1) have subsequent recrudescent infection, or (2) were cured by Day 28 following treatment. Using a Plasmodium falciparum antigen library, we examined the antibody specificities in these sera. While the antibody repertoire of both sera groups was extremely broad and varied, there was a differential antibody profile between the two groups of sera. The proportion of cured patients with antibodies against EXP1, MSP3, GLURP, RAMA, SEA and EBA181 was higher than the proportion of patients with recrudescent infection. The presence of these antibodies was associated with higher odds of treatment cure. Sera containing all six antibodies impaired the invasion of P. falciparum clinical isolates into erythrocytes. These results suggest that antibodies specific against EXP1, MSP3, GLURP, RAMA, SEA and EBA181 in P. falciparum infections could assist anti-malarial drug treatment and contribute to the resolution of the malarial infection.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: Laurent Renia, Francois Nosten and Nicholas J. White are academic editors for PLOS ONE.

Figures

Fig 1
Fig 1. Antibody-mediated inhibition of Pf RBC invasion.
RBC invasion inhibition efficiency, mediated by the human patients sera, was defined as the ratio of the subtraction of parasitemia in the test well (test patients sera) from the parasitemia in the control well (normal human serum) to the parasitemia in the control well, expressed as a percentage. 6Ab +ve refers to sera (both cured and recrudescent sera) containing specific antibodies against all six antigens (n = 14); Cured 5Ab +ve refers to cured sera containing specific antibodies against the five antigens (n = 14); 6Ab–ve refers to sera (both cured and recrudescent sera) with absence of specific antibodies against the six antigens (n = 6); Recrudescent 5Ab +ve refers to recrudescent sera containing specific antibodies against the five antigens (n = 7). Pooled cured refers to sera pooled from all cured patients (n = 40) and pooled recrudescent refers to sera pooled from all recrudescent patients (n = 28). Each point in graph represents one P. falciparum isolate (n = 12). Horizontal line in graph represents mean inhibition efficiency between the 12 P. falciparum isolates. * denotes p <0.05; ** denotes p <0.01; *** denotes p <0.001; **** denotes p <0.0001, by Mann-Whitney U-test (adjusted for multiple comparison using Bonferroni correction).

Similar articles

Cited by

References

    1. WHO. Malaria factsheet. 2015; Available: http://www.cdc.gov/malaria/about/facts.html. Accessed 7 June 2016.
    1. Greenwood BM, Fidock DA, Kyle DE, Kappe SH, Alonso PL, Collins FH, et al. Malaria: progress, perils, and prospects for eradication. J Clin Invest. 2008;118: 1266–1276. Epub 2008/04/03. 10.1172/JCI33996 - DOI - PMC - PubMed
    1. Crompton PD, Miura K, Traore B, Kayentao K, Ongoiba A, Weiss G, et al. In vitro growth-inhibitory activity and malaria risk in a cohort study in mali. Infect Immun. 2010;78: 737–745. Epub 2009/11/18. 10.1128/IAI.00960-09 - DOI - PMC - PubMed
    1. Gupta S, Snow RW, Donnelly C, Newbold C. Acquired immunity and postnatal clinical protection in childhood cerebral malaria. Proc Biol Sci. 1999;266: 33–38. Epub 1999/03/19. - PMC - PubMed
    1. Schofield L, Mueller I. Clinical immunity to malaria. Curr Mol Med. 2006;6: 205–221. Epub 2006/03/07. - PubMed

MeSH terms

LinkOut - more resources